These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10678495)

  • 41. Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease.
    Henning J; Strauss U; Wree A; Gimsa J; Rolfs A; Benecke R; Gimsa U
    Neurosci Res; 2008 Dec; 62(4):246-53. PubMed ID: 18824050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat.
    Penttinen AM; Suleymanova I; Albert K; Anttila J; Voutilainen MH; Airavaara M
    J Neurosci Res; 2016 Apr; 94(4):318-28. PubMed ID: 26762168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Respiratory pattern and phrenic and hypoglossal nerve activity during normoxia and hypoxia in 6-OHDA-induced bilateral model of Parkinson's disease.
    Andrzejewski K; Jampolska M; Zaremba M; Joniec-Maciejak I; Boguszewski PM; Kaczyńska K
    J Physiol Sci; 2020 Mar; 70(1):16. PubMed ID: 32160868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats.
    Massie A; Schallier A; Mertens B; Vermoesen K; Bannai S; Sato H; Smolders I; Michotte Y
    Neuroreport; 2008 Oct; 19(16):1589-92. PubMed ID: 18806690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.
    De Klippel N; Sarre S; Ebinger G; Michotte Y
    Brain Res; 1993 Dec; 630(1-2):57-64. PubMed ID: 8118706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A continuous striatal infusion of 6-hydroxydopamine produces a terminal axotomy and delayed behavioral effects.
    Jones BE; Boylan CB; Fritsche M; Juhasz M; Jackson C; Wiegand SJ; Hyman C; Lindsay RM; Altar CA
    Brain Res; 1996 Feb; 709(2):275-84. PubMed ID: 8833764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of endogenous melatonin on glutamate and GABA rhythms in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
    Meng T; Yuan S; Zheng Z; Liu T; Lin L
    Neuroscience; 2015 Feb; 286():308-15. PubMed ID: 25499317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats.
    Grant RJ; Sellings LH; Crocker SJ; Melloni E; Park DS; Clarke PB
    Neuroscience; 2009 Jan; 158(2):558-69. PubMed ID: 19007862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ; Reisman SA; Stanford JA
    Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.
    Espino A; Llorens J; Calopa M; Bartrons R; Rodriguez-Farré E; Ambrosio S
    Brain Res; 1995 Jan; 669(1):19-25. PubMed ID: 7712161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism.
    Senthilkumar KS; Saravanan KS; Chandra G; Sindhu KM; Jayakrishnan A; Mohanakumar KP
    Behav Brain Res; 2007 Nov; 184(1):11-8. PubMed ID: 17765334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
    Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further validation of the corridor task for assessing deficit and recovery in the hemi-Parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism.
    Fitzsimmons DF; Moloney TC; Dowd E
    Behav Brain Res; 2006 May; 169(2):352-5. PubMed ID: 16488026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
    Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
    J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Shimizu M; Tanaka K; Ogawa N
    Neurol Res; 2005 Jul; 27(5):533-9. PubMed ID: 15978181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
    Han B; Jin HJ; Song MY; Wang T; Zhao H
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I; Kehr J; Andbjer B; Fuxe K
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.